Conclusions
T1D, PGHD
The ability to access patient-generated glucose data remotely has opened the door for new models of T1D care that are more individualized in terms of the frequency and timing of outreach. Such models have the potential to be more responsive to patient needs, to enable more efficient and effective use of clinician time and practice resources, and thus to improve not only individual health outcomes but also health equity within T1D patient populations. In comparison, current care models are prescriptive (scheduled quarterly visits) and tend to prioritize between-visit care for patients with the highest health literacy and self-efficacy (those who initiate supplemental telephone and EHR messaging encounters with their clinicians).Patient and provider openness to telehealth care modalities – including remote monitoring of PGHD and asynchronous electronic interaction – has increased with the rapid uptick in telehealth use necessitated by the COVID-19 pandemic (